A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Name: A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)
Published: 2014
License: Public Domain

Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

pancreatic-ductal-adenocarcinoma triple-negative-breast-cancer

nut midline carcinoma, triple negative breast cancer, non-small cell lung cancer with rearranged alk gene/fusion protein or kras mutation, castrate-resistant prostate cancer, crpc, pancreatic ductal adenocarcinoma, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Related documents